Many Nu Skin Enterprises, Inc.(NUS) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Nu Skin Enterprises was Upgraded by Sidoti to Buy on Dec 8, 2016.
Company has reported several Insider transactions to the SEC, on Jan 9, 2017, D Matthew Dorny (General Counsel) sold 8,000 shares at 50.00 per share price.On Oct 28, 2016, Steven Lund (Exec. Chairman of the Board) sold 61,000 shares at 61.54 per share price.On Sep 23, 2016, Andrew D Lipman (director) sold 30,000 shares at 64.13 per share price.
Nu Skin Enterprises Last issued its quarterly earnings results on Nov 3, 2016. The company reported $0.91 EPS for the quarter, beating the analyst consensus estimate by $ 0.08. Analyst had a consensus of $0.83. The company had revenue of $604.00 million for the quarter, compared to analysts expectations of $585.91 million. The companys revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.71 EPS.
Nu Skin Enterprises, Inc. (NYSE:NUS) has received a short term rating of sell from experts at Zacks with a rank of 4. The stock has been rated an average of 2.8 by 5 Brokerage Firm. 2 Wall Street Firms have rated the stock as a strong buys. 1 Brokerage Firms have advised hold. 1 Analysts have rated it as strong sell. A sell rating was given by 1 analyst.
Nu Skin Enterprises, Inc. (NYSE:NUS) stock has received a short term price target of $ 54.2 from 5 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $7.98. The higher estimate of target price is $63 , while the lower price target estimate is $43
Nu Skin Enterprises, Inc. (NYSE:NUS) rose 1.76% or 0.94 points on Tuesday and made its way into the gainers of the day. After trading began at $53.46 the stock was seen hitting $54.58 as a peak level and $53.2 as the lowest level. The stock ended up at $54.43. The daily volume was measured at 614,201 shares. The 52-week high of the share price is $66.04 and the 52-week low is $27.628. The company has a market cap of $2,964 million.
Nu Skin is a premier anti-aging company. The companys anti-aging products feature the ageLOC line of products including ageLOC Tru Face Essence Ultra firming serum, the ageLOC TR90 weight management and body shaping system, ageLOC R2 nutritional supplement, and ageLOC Transformation daily skin care system.